Middle East, North Africa, Afghanistan & Pakistan (excluding high income) vs Sierra Leone: Access to anti-retroviral drugs, female
Access to anti-retroviral drugs, female over time
- Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
- Sierra Leone
How they compare
Sierra Leone currently reports 95.0% against 38.4% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), a difference of 56.6%.
That makes Sierra Leone's figure about 2.5 times Middle East, North Africa, Afghanistan & Pakistan (excluding high income)'s.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ahead.
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 18th and Sierra Leone ranks 19th of 19 groups.
Across the 3 decades both report, Middle East, North Africa, Afghanistan & Pakistan (excluding high income) averaged higher in 1 and Sierra Leone in 2.
Head to head by decade
| Decade | Middle East, North Africa, Afghanistan & Pakistan (excluding high income) | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.8% | 1.5% | 2.3% | Middle East, North Africa, Afghanistan & Pakistan (excluding high income) |
| 2010s | 20.3% | 28.4% | 8.1% | Sierra Leone |
| 2020s | 34.3% | 80.4% | 46.1% | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Middle East, North Africa, Afghanistan & Pakistan (excluding high income) or Sierra Leone?
- Sierra Leone, at 95.0% against 38.4% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Sierra Leone?
- 56.6%, with Sierra Leone ahead.
- How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Sierra Leone?
- 25 years are reported by both, from 2000 to 2024.
- How do Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Sierra Leone rank globally for access to anti-retroviral drugs, female?
- Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 18th and Sierra Leone ranks 19th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.